Author

Amin Rakhshan

Observed name: Rakhshan, Amin

Institutions: Lorestan University of Medical Sciences, Lorestan University

Observed institutions: Ahvaz Jundishapur University of Medical Sciences, Lorestan University of Medical Sciences, Lorestan University, Shahid Beheshti University, Shahid Beheshti University of Medical Sciences

ORCID: 0000-0002-1836-7658

Observed ORCID: 0000-0002-1836-7658

OpenAlex ID: A5041809606

Hepatotoxicity Induced by Azole Antifungal Agents: A Review Study

2023 · Amin Rakhshan, Bardia Rahmati Kamel, et al. · Iranian journal of pharmaceutical research · 38

Adverse Drug Reactions: Knowledge, Attitude and Practice of Pharmacy Students

2013 · Maryam Etminani Isfahani, Sarah Mousavi, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 16

Evaluating the efficacy of inhaled amikacin as an adjunct to intravenous combination therapy (ceftazidime and amikacin) in pediatric cystic fibrosis pulmonary exacerbation

2023 · Amin Rakhshan, Nazanin Farahbakhsh, et al. · Frontiers in Pharmacology · 6

Optimal dosing interval of intravenous Colistin monotherapy versus combination therapy: A systematic review and meta-analysis

2022 · Forouzan Ahmadpour, Elnaz Shaseb, et al. · European Journal of Translational Myology · 5

A Review on Different Virtual Learning Methods in Pharmacy Education

2015 · Amin Noori, Leila Kouti, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 5

Protective effects of crocin against contrast induced acute kidney injury following angiography: A randomized controlled clinical trial.

2025 · Arefe Khani, Javad Khalili Fard, et al. · PubMed Central · 1

Evaluation and improvement of venous thromboembolism prophylaxis pattern in patients admitted to orthopedic ward in a tertiary teaching hospital: Improvement of VTE prophylaxis

2022 · Tavakoli-Ardakani, Maria, Jafarinejad, Farinaz, et al. · International Pharmacy Acta

Works count: 7

Citation count: 71

H-index: 5

I10-index: 2